JERUSALEM--(BUSINESS WIRE)--Dec. 5, 2011--
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live
audio webcast at the NASDAQ OMX 27th Investor Program with
Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries
Ltd., presenting on Tuesday, December 6, 2011 in London.
|
What:
|
|
Teva Presentation at the NASDAQ OMX 27th Investor Program
|
|
|
|
|
|
Who:
|
|
Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries
Ltd.
|
|
|
|
|
|
When:
|
|
Tuesday, December 6, 2011 at 5:15 am EST (10:15 am GMT)
|
|
|
|
|
|
Where:
|
|
http://investor.shareholder.com/NDQCCG/london_dec2011/eventdetail.cfm?eventid=105938
|
|
|
|
|
|
How:
|
|
Live over the Internet – log on to the Web at the address above and
register for the event (approx. 10 minutes before). An archive of
the webcast will be available on Teva’s website.
|
About Teva
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic
drugs as well as innovative and specialty pharmaceuticals and active
pharmaceutical ingredients. Headquartered in Israel, Teva is the world's
largest generic drug maker, with a global product portfolio of more than
1,300 molecules and a direct presence in about 60 countries. Teva's
branded businesses focus on CNS, oncology, pain, respiratory and women's
health therapeutic areas as well as biologics. Teva currently employs
approximately 45,000 people around the world and reached $16.1 billion
in net sales in 2010.
Source: Teva Pharmaceutical Industries Ltd.
IR:
Teva Pharmaceutical Industries Ltd.
Elana Holzman,
972 (3) 926-7554
or
Teva North America
Kevin C. Mannix,
215-591-8912
or
PR:
Teva Pharmaceutical Industries Ltd.
Yossi
Koren, 972 (3) 926-7687
or
Teva North America
Denise
Bradley, 215-591-8974